Canada Life
TRIB

Canada Life’s Trinity Biotech TRIB Stock Holding History

Canada Life’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-840
Closed -$78K – 2567
2015
Q2 		$78K Hold
840
– – ﹤0.01% 2021
2015
Q1 		$75K Hold
840
– – ﹤0.01% 1956
2014
Q4 		$71K Hold
840
– – ﹤0.01% 1954
2014
Q3 		$82K Hold
840
– – ﹤0.01% 1828
2014
Q2 		$101K Hold
840
– – ﹤0.01% 1577
2014
Q1 		$111K Hold
840
– – ﹤0.01% 1384
2013
Q4 		$108K Hold
840
– – ﹤0.01% 1389
2013
Q3 		$83K Buy
+840
New +$81.9K ﹤0.01% 997

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Canada Life's TRIB Position: Q3 2015 in Review

Canada Life sold out of Trinity Biotech (TRIB) in Q3 2015, closing a stake of 840 shares — an estimated $78K sold.

Canada Life first reported a position in TRIB in Q3 2013 and held it in 8 quarters. The position peaked at $111K in Q1 2014. 92 funds tracked by Wall St. Rank hold TRIB as of Q3 2015.

  • Canada Life reported no remaining Trinity Biotech position as of Q3 2015 after selling out during the quarter.
  • Canada Life sold 840 Trinity Biotech shares in Q3 2015, an estimated $78K.
  • Canada Life first reported a position in Trinity Biotech in Q3 2013 and held it in 8 quarters.
  • Canada Life's Trinity Biotech position peaked at $111K in Q1 2014.
  • 92 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2015.

Based on Canada Life's 13F filing for Q3 2015, filed 10 Nov 2015.